Abstract
No public abstract is available from the verified source records.
Chetan Shenoy
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
CMR-Based differentiation of AL and ATTR cardiac amyloidosis
10.1016/j.jcmg.2013.08.015 · 2014
Multi-imaging characterization of cardiac phenotype in different types of amyloidosis
10.1016/j.jcmg.2022.07.008 · 2023
Rare forms of cardiac amyloidosis: diagnostic clues and phenotype in apo AI and AIV amyloidosis
10.1161/circimaging.123.015259 · 2023
Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis
10.1001/jamacardio.2024.2555 · 2024
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
10.1093/eurheartj/ehac363 · 2022
Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping
10.1001/jamacardio.2023.2010 · 2023
Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis
10.1001/jamacardio.2022.2981 · 2022
Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta‐analysis of gross pathological images from autopsy or cardiac transplantation cases
10.1161/jaha.118.011253 · 2019
Late gadolinium enhancement on cardiac magnetic resonance in suspected cardiac sarcoidosis
10.1016/j.jcmg.2022.11.022 · 2023
Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement
10.1093/eurheartj/ehaf338 · 2025
Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement
10.1093/eurheartj/ehaf338 · doi-reference
Late gadolinium enhancement on cardiac magnetic resonance in suspected cardiac sarcoidosis
10.1016/j.jcmg.2022.11.022 · doi-reference
Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta‐analysis of gross pathological images from autopsy or cardiac transplantation cases
10.1161/jaha.118.011253 · doi-reference
Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis
10.1001/jamacardio.2022.2981 · doi-reference
Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping
10.1001/jamacardio.2023.2010 · doi-reference
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
10.1093/eurheartj/ehac363 · doi-reference
Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis
10.1001/jamacardio.2024.2555 · doi-reference
Rare forms of cardiac amyloidosis: diagnostic clues and phenotype in apo AI and AIV amyloidosis
10.1161/circimaging.123.015259 · doi-reference
Multi-imaging characterization of cardiac phenotype in different types of amyloidosis
10.1016/j.jcmg.2022.07.008 · doi-reference
CMR-Based differentiation of AL and ATTR cardiac amyloidosis
10.1016/j.jcmg.2013.08.015 · doi-reference